KAYDENCE PHARMA UPDATE
Oslo, Norway (30 June 2020) At the Annual General Meeting (“AGM”) today of Kaydence Pharma AS (“Kaydence Pharma”) it has been decided that NattoPharma ASA (“NattoPharma”) will convert NOK 4 million of its loans to equity in Kaydence Pharma. The loan will be converted at NOK 5 per share giving NattoPharma a total number of 3 000 000 shares representing a 54.15% interest as at 30 June 2020. Following the conversion, NattoPharma´s loan to Kaydence Pharma is NOK 51 million. Further the AGM decided that the Board of Kaydence Pharma has been replaced with Kjetil Ramsøy as Chairman of the